Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril

S E Nielsen; K J Schjoedt; A S Astrup; Lise Tarnow; Marianne Lajer; P R Hansen; H-H Parving; Pia Rossing

doi:10.1111/j.1464-5491.2010.03083.x

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril

S E Nielsen
, K J Schjoedt
, A S Astrup
, Lise Tarnow
, Marianne Lajer
, P R Hansen
, H-H Parving
, Pia Rossing

Department of Clinical Medicine

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

Our aim was to evaluate the markers of tubulointerstitial damage, neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule1 (KIM1) in Type 1 diabetic patients with different levels of albuminuria and in control subjects. In addition, the effect of renoprotective treatment on urinary NGAL was evaluated in diabetic nephropathy.

Original language	English
Journal	Diabetic Medicine
Volume	27
Issue number	10
Pages (from-to)	1144-50
Number of pages	7
ISSN	0742-3071
DOIs	https://doi.org/10.1111/j.1464-5491.2010.03083.x
Publication status	Published - 1 Oct 2010

Access to Document

10.1111/j.1464-5491.2010.03083.x

Library access?

Check availability at the Royal Danish Library

Cite this

Nielsen, S. E., Schjoedt, K. J., Astrup, A. S., Tarnow, L., Lajer, M., Hansen, P. R., Parving, H.-H., & Rossing, P. (2010). Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabetic Medicine, 27(10), 1144-50. https://doi.org/10.1111/j.1464-5491.2010.03083.x

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. / Nielsen, S E; Schjoedt, K J; Astrup, A S et al.
In: Diabetic Medicine, Vol. 27, No. 10, 01.10.2010, p. 1144-50.

Research output: Contribution to journal › Journal article › Research › peer-review

Nielsen, SE, Schjoedt, KJ, Astrup, AS, Tarnow, L, Lajer, M, Hansen, PR, Parving, H-H & Rossing, P 2010, 'Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril', Diabetic Medicine, vol. 27, no. 10, pp. 1144-50. https://doi.org/10.1111/j.1464-5491.2010.03083.x

@article{aa9cdfa0ad5a4513b3fb6101aa9a6fd5,

title = "Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril",

abstract = "Our aim was to evaluate the markers of tubulointerstitial damage, neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule1 (KIM1) in Type 1 diabetic patients with different levels of albuminuria and in control subjects. In addition, the effect of renoprotective treatment on urinary NGAL was evaluated in diabetic nephropathy.",

author = "Nielsen, \{S E\} and Schjoedt, \{K J\} and Astrup, \{A S\} and Lise Tarnow and Marianne Lajer and Hansen, \{P R\} and H-H Parving and Pia Rossing",

note = "{\textcopyright} 2010 The Authors. Diabetic Medicine {\textcopyright} 2010 Diabetes UK.",

year = "2010",

month = oct,

day = "1",

doi = "10.1111/j.1464-5491.2010.03083.x",

language = "English",

volume = "27",

pages = "1144--50",

journal = "Diabetic Medicine",

issn = "0742-3071",

publisher = "Wiley-Blackwell",

number = "10",

}

TY - JOUR

T1 - Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril

AU - Nielsen, S E

AU - Schjoedt, K J

AU - Astrup, A S

AU - Tarnow, Lise

AU - Lajer, Marianne

AU - Hansen, P R

AU - Parving, H-H

AU - Rossing, Pia

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Our aim was to evaluate the markers of tubulointerstitial damage, neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule1 (KIM1) in Type 1 diabetic patients with different levels of albuminuria and in control subjects. In addition, the effect of renoprotective treatment on urinary NGAL was evaluated in diabetic nephropathy.

AB - Our aim was to evaluate the markers of tubulointerstitial damage, neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule1 (KIM1) in Type 1 diabetic patients with different levels of albuminuria and in control subjects. In addition, the effect of renoprotective treatment on urinary NGAL was evaluated in diabetic nephropathy.

U2 - 10.1111/j.1464-5491.2010.03083.x

DO - 10.1111/j.1464-5491.2010.03083.x

M3 - Journal article

SN - 0742-3071

VL - 27

SP - 1144

EP - 1150

JO - Diabetic Medicine

JF - Diabetic Medicine

IS - 10

ER -